mRNA |
N9-isopropylolomoucine |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
BRD-K04800985 |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.4 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
KPT185 |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.4 |
mRNA |
regorafenib |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
NVP-231 |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.4 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
VER-155008 |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
5-FU |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.045 |
0.4 |